Groundbreaking New Regimen for Advanced Hodgkin Lymphoma Groundbreaking New Regimen for Advanced Hodgkin Lymphoma

Nivolumab instead of brentuximab added onto chemotherapy is suggested as the new standard of care, based on results from the largest Hodgkin lymphoma study in National Clinical Trials Network history.MDedge News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news